(Q79774734)

English

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study

scientific article published on 01 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Effect of teriparatide on bone mineral density and biochemical markers in Japanese women with postmenopausal osteoporosis: a 6-month dose-response study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

postmenopausal osteoporosis

1 reference

based on heuristic

inferred from title

author name string

Akimitsu Miyauchi

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Toshio Matsumoto

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Hirofumi Shigeta

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Mika Tsujimoto

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Daniel Thiebaud

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Toshitaka Nakamura

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

publication date

1 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Journal of Bone and Mineral Metabolism

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

26

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

624-634

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

https://scigraph.springernature.com/pub.10.1007/s00774-008-0871-3

0 references

Proteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts. A putative explanation for why intermittent administration is needed for bone anabolism

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intermittent administration of human parathyroid Hormone(1-34) prevents immobilization-related bone loss by regulating bone marrow capacity for bone cells in ddY mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of osteoporosis medications on bone quality

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide increases bone formation in modeling and remodeling osteons and enhances IGF-II immunoreactivity in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of teriparatide and calcitonin therapy in postmenopausal Asian women with osteoporosis: a 6-month study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Daily nasal spray of hPTH(1-34) for 3 months increases bone mass in osteoporotic subjects: a pilot study

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Treatment of established osteoporosis: a systematic review and cost-utility analysis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The anabolic effects of parathyroid hormone therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone formation correlate with improvements in bone structure during teriparatide therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early histomorphometric changes in response to parathyroid hormone therapy in osteoporosis: evidence for de novo bone formation on quiescent cancellous surfaces

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Teriparatide vs. calcitonin in the treatment of Asian postmenopausal women with established osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The treatment of severe postmenopausal osteoporosis : a review of current and emerging therapeutic options

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Change in lumbar spine BMD and vertebral fracture risk reduction in teriparatide-treated postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Early changes in biochemical markers of bone formation predict BMD response to teriparatide in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Assessment of fracture risk

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recombinant Human Parathyroid Hormone (1–34) [Teriparatide] Improves Both Cortical and Cancellous Bone Structure

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanisms of anabolic therapies for osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Opposite bone remodeling effects of teriparatide and alendronate in increasing bone mass

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of teriparatide [recombinant human parathyroid hormone (1-34)] on cortical bone in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Development of an algorithm for using PINP to monitor treatment of patients with teriparatide.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increases in BMD correlate with improvements in bone microarchitecture with teriparatide treatment in postmenopausal women with osteoporosis.

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Features of limb fractures: a review of epidemiology from a Japanese perspective

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A novel tetracycline labeling schedule for longitudinal evaluation of the short-term effects of anabolic therapy with a single iliac crest bone biopsy: early actions of teriparatide

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The skeletal response to teriparatide is largely independent of age, initial bone mineral density, and prevalent vertebral fractures in postmenopausal women with osteoporosis

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of an intermittent weekly dose of human parathyroid hormone (1-34) on osteoporosis: a randomized double-masked prospective study using three dose levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/18979163

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00774-008-0871-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18979163%20AND%20SRC:MED&resulttype=core&format=json

25 December 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q79774734&oldid=2125089517"